SESAME stent
Pre-clinical- Indications
- Coronary artery disease
Company intelligence / Profile preview
Palmaz Scientific
Dallas, Texas, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Palmaz Scientific developed a proprietary nanotechnology platform for manufacturing advanced implantable medical devices such as stents and balloons. Their thin film micromesh stent technology aimed to improve healing and reduce complications. The company held over 250 patents but filed for bankruptcy in 2016 before commercializing its products.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- DeviceDrug delivery platform
- Industry
- Implantable Medical Devices
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Palmaz Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Palmaz Scientific.